Mixing machine learning with fertility technology could be a science fiction plot. It can also be a company. Felicia von Reden started Ovom Care in 2023 to build software to make the often strenuous IVF process more efficient and more affordable. Ovom uses artificial intelligence to help doctors determine the right medication and dosage for each patient, and even identify the most viable eggs and sperm in a patient’s body. “What makes this company unique is that we have two parts: technical innovation with AI and data, and medical care at the clinic,” she said. “Only if you bring the two together can you develop innovation that brings that value to the patient.” Valued at $22 million, Ovom has brought in $8 million in funding to develop the technology. Investors, including Alpha Intelligence Capital, have invested $8 million at a $22 million valuation. In 2024, it opened its first clinic and has treated more than 350 women.
